Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

June 2021 Vol 7 No 3

Staying Positive, with Purpose

Emotional Rollercoaster of Cancer
In this heartfelt poem, Priya Kalra writes about riding the challenging waves of emotions after being diagnosed with breast cancer in December 2017. Read More ›

Conquering the World in My Mom’s Memory
Speech-language pathologist Stacey Brill, MS, CCC-SLP, shares her journey by her mom’s side as she battled cancer, and the subsequent care and services she had provided to many patients with cancer, in her mom’s memory. Read More ›

Rybrevant First FDA-Approved Therapy for Lung Cancer with EGFR Exon 20 Insertion Mutations
In May 2021, the FDA approved Rybrevant (amivantamab-vmjw), an intravenous antibody that targets mutations in the EGFR and MET pathways, for the treatment of adults with non–small-cell lung cancer and EGFR exon 20 insertion mutations. This is the first drug approved for lung cancer with EGFR exon 20 insertion mutations. Read More ›

Lumakras First FDA-Approved Drug for Advanced Lung Cancer and KRAS G12C Mutation
In May 2021, the FDA approved Lumakras (sotorasib), an oral KRAS inhibitor, for the treatment of adults with locally advanced or metastatic non–small-cell lung cancer associated with KRAS G12C mutation. Lumakras is the first drug approved for any cancer associated with any KRAS mutation. Read More ›

Zynlonta First FDA-Approved CD19-Targeted Therapy for Large B-Cell Lymphoma
In April 2021, the FDA approved Zynlonta (loncastuximab tesirine), the first CD19-directed antibody–drug conjugate, for the treatment of patients with relapsed or refractory large B-cell lymphoma. Read More ›

Why a Healthy Diet Is So Important for Patients with Gastric Cancer
“Because gastric cancers involve the digestive system, following a healthy diet is especially important for patients with this type of cancer,” says Martha Raymond, Founding Executive Director of the GI Cancers Alliance. Read More ›

Sarclisa Now Approved for Relapsed or Refractory Multiple Myeloma
In March 2021, the FDA approved a new indication for Sarclisa (isatuximab-irfc), in combination with Kyprolis and dexamethasone, for the treatment of adults with relapsed or refractory multiple myeloma. Read More ›

The Birth of the Cancer Survivorship Movement
Judy Pearson offers a compelling and inspiring historical perspective of the formation of the cancer survivorship movement in the United States, and what this means to cancer survivors today. Read More ›

Courage Through Cancer
Kristen Foreman dealt with an ovarian cancer diagnosis at age 33. After removal of her ovaries, she completed chemotherapy, followed by 6 weeks of radiation, during a global pandemic. She now aspires to support others facing similar circumstances. Read More ›

Page 1 of 2